| Long-term outcome of anti–glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression JB Levy, AN Turner, AJ Rees, CD Pusey Annals of internal medicine 134 (11), 1033-1042, 2001 | 759 | 2001 |
| Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids MB Condon, D Ashby, RJ Pepper, HT Cook, JB Levy, M Griffith, TD Cairns, ... Annals of the rheumatic diseases 72 (8), 1280-1286, 2013 | 526 | 2013 |
| Prospective study of TNFα blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis A Booth, L Harper, T Hammad, P Bacon, M Griffith, J Levy, C Savage, ... Journal of the American Society of Nephrology 15 (3), 717-721, 2004 | 488 | 2004 |
| Clinical features and outcome of patients with both ANCA and anti-GBM antibodies JB Levy, T Hammad, A Coulthart, T Dougan, CD Pusey Kidney international 66 (4), 1535-1540, 2004 | 428 | 2004 |
| Oxford handbook of dialysis J Levy, E Brown, A Lawrence Oxford university press, 2016 | 318 | 2016 |
| Goodpasture's disease AD Salama, JB Levy, L Lightstone, CD Pusey The Lancet 358 (9285), 917-920, 2001 | 250 | 2001 |
| Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients SP McAdoo, A Tanna, Z Hrušková, L Holm, M Weiner, N Arulkumaran, ... Kidney international 92 (3), 693-702, 2017 | 224 | 2017 |
| Renal association clinical practice guideline on haemodialysis D Ashby, N Borman, J Burton, R Corbett, A Davenport, K Farrington, ... BMC nephrology 20, 1-36, 2019 | 208 | 2019 |
| Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids R Pepper, M Griffith, C Kirwan, J Levy, D Taube, C Pusey, L Lightstone, ... Nephrology Dialysis Transplantation 24 (12), 3717-3723, 2009 | 199 | 2009 |
| Peritoneal dialysis catheter removal for acute peritonitis: a retrospective analysis of factors associated with catheter removal and prolonged postoperative hospitalization P Choi, E Nemati, A Banerjee, E Preston, J Levy, E Brown American journal of kidney diseases 43 (1), 103-111, 2004 | 175 | 2004 |
| Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques AD Salama, T Dougan, JB Levy, HT Cook, SH Morgan, S Naudeer, ... American journal of kidney diseases 39 (6), 1162-1167, 2002 | 173 | 2002 |
| Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis SP McAdoo, N Medjeral-Thomas, S Gopaluni, A Tanna, N Mansfield, ... Nephrology Dialysis Transplantation 34 (1), 63-73, 2019 | 156 | 2019 |
| Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis FWK Tam, JS Sanders, A George, T Hammad, C Miller, T Dougan, ... Nephrology Dialysis Transplantation 19 (11), 2761-2768, 2004 | 152 | 2004 |
| The timing of compaction: control of a major developmental transition in mouse early embryogenesis JB Levy, MH Johnson, H Goodall, B Maro’ Development 95 (1), 213-237, 1986 | 152 | 1986 |
| Antiretrovirals and the kidney in current clinical practice: renal pharmacokinetics, alterations of renal function and renal toxicity JC Yombi, A Pozniak, M Boffito, R Jones, S Khoo, J Levy, FA Post Aids 28 (5), 621-632, 2014 | 147 | 2014 |
| A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody–associated vasculitis RJ Pepper, SP McAdoo, SM Moran, D Kelly, J Scott, S Hamour, A Burns, ... Rheumatology 58 (2), 260-268, 2019 | 130 | 2019 |
| Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors A Tanna, L Guarino, FWK Tam, B Rodriquez-Cubillo, JB Levy, TD Cairns, ... Nephrology Dialysis Transplantation 30 (7), 1185-1192, 2015 | 124 | 2015 |
| Recurrent glomerulonephritis following renal transplantation P Kotanko, CD Pusey, JB Levy Transplantation 63 (8), 1045-1052, 1997 | 104 | 1997 |
| Nephrotoxicity of intravenous immunoglobulin JB Levy, CD Pusey Qjm 93 (11), 751-755, 2000 | 102 | 2000 |
| In Goodpasture's disease, CD4+ T cells escape thymic deletion and are reactive with the autoantigen α3 (IV) NC1 AD Salama, AN Chaudhry, JJ Ryan, E Eren, JB Levy, CD Pusey, ... Journal of the American Society of Nephrology 12 (9), 1908-1915, 2001 | 98 | 2001 |
